In a research report issued today, RBC Capital analyst Adnan Butt initiated coverage on shares of Synthetic Biologics Inc (NYSEMKT:SYN), with an Outperform …
In a research report published on Monday, RBC Capital analyst Adnan Butt reiterated an Outperform rating on shares of MannKind Corporation (NASDAQ:MNKD), but reduced the …
Investors are patiently awaiting the results of XOMA Corp’s (NASDAQ:XOMA) EYEGUARD B Phase III trial. Shares of the company last closed at $4.
Aerie Pharmaceuticals Inc (NASDAQ:AERI) shares shot up 56% to $20.75 in pre-market trading after the FDA agreed to allow Aerie to change the …
RBC Capital analyst Adnan Butt weighed in with some commentary on Aerie Pharmaceuticals Inc (NASDAQ:AERI) following an FDA agreement that the company may change the primary endpoint …
RBC Capital analyst Adnan Butt was out pounding the table with Regeneron Pharmaceuticals Inc (NASDAQ:REGN), reiterating an Outperform rating on the stock and boosting the price …
RBC Capital analyst Adnan Butt came out with a research report on Regeneron Pharmaceuticals Inc (NASDAQ:REGN) following an FDA panel recommendation for the approval of Regeneron …